Login
Toggle navigation
Videos
Categories
Trending
Research: It's All About Patients - Dr. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Research: It's All About Patients
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
"Navigating Opportunities and Risks in Performing Credit: Armen Panossian and Danielle Poli Reflect on 2020 and Look Ahead in Oaktree's 'Insights Live' Series"
00:10:00
Blue Owl Capital's Role in Stable Investment Solutions | Marc Lipschultz, Co-president , Blue Owl Capital.
00:10:00
Addressing the Global Plastic Crisis: Innovative Recycling Solutions for Polyester Fiber | Daniel Solomita, CEO, Loop Industries Inc.
00:10:00
Tomorrow's Company interviews Roger Parry CBE, Chairman of YouGov plc and Oxford Metrics plc, as well as Peter Taylor.
00:10:00
A Deep Dive into Brazil's Energy Sector Growth and Challenges | Gustavo Estrella , CEO, CPFL Energia SA.
00:10:00
MP Training Demo: 2019 nCONNECT Cebu Presentation
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.
00:10:00
Henderson Land Honored in Singapore with Second 'Developer of the Year' Award|Mr Yu Ching Yan Johnny,Advisor to Chairman,Henderson Land Development Co. Ltd.
00:10:00
Balancing Risk and Innovation: Ken Fisher on Global Finance and Market Trends | Ken Fisher, founder , Fisher Investments.
00:10:00
Key Career Advice and Future Trends in the Water Sector | Liv Garfield, Managing Director ,Severn Trent PLC.
00:10:00
Concurrent Technologies (AIM) CEO Miles Adcock presents at the Cenkos Securities PLC (AIM) Virtual Growth & Innovation Forum.| Miles John Adcock occupies the position of Chief Executive Officer & Executive Director at Concurrent Technologies Plc.
00:10:00
Billions of people got access to amazing technologies|Julie Yoo,General Partner,Andreessen Horowitz